Seeking Alpha


Send Message
View as an RSS Feed
View bullrunner911's Comments BY TICKER:
Latest comments  |  Highest rated
  • Amarin: Mr. NCE Guy Has Left The Building [View article]
    Actually a very few people expected an NCE decision. I even commented that their wont be one. Not sure what planet you live on but mgmt. mentioned that they are still pressing on the FDA to make a decision last week. So please tell me how you come to the conclusion that an NCE decision was coming or that even anyone cares. The stock did not rise or fall before and afterwords. If you want to some bid deal over .05 moves go ahead. The only thing that matters is patents, sales and anchor.

    That is a check, check, check. Please short some more.
    Jun 17, 2013. 02:57 AM | 7 Likes Like |Link to Comment
  • Amarin Investors Should Avoid The Bear Traps [View article]
    Adam Fartstain is correct about not being short on AMRN. He is not short but the higher ups on the chain are. Adam is a pawn just like the article writers that wrote the fish oil articles only linking AMRN in the their articles. All you have to do is google Adam Feuerstein and any of those article writers to see the links going back years bashing the same stocks and re-tweeting each other. So when he says he is not short he is technically correct. He is told what stocks to bash. Anyone surprised that not only Adam Feuerstein has bashed MNKD but so has the Just look at Friday pm street comments on MNKD. Stock was only down .25. Every comment these guys make regarding Amrn or Mnkd is negative. Just so happens every stock they bash is highly shorted. What a coincidence. It is not a coincidence. Its possible Adam does not even know who is short as he is probably kept in the dark as to avoid ties in any lawsuits. So he can keep saying he is not short on AMRN but he knows what is going on here. But its ok. I'll be a constant reminder to him for years to come on his calls on ARNA, MNKD and what will be AMRN.
    Jun 10, 2013. 09:30 PM | 5 Likes Like |Link to Comment
  • Italian OTC Fish Oil Study Has No Bearing On Vascepa Outcomes [View instapost]
    Adam and his article writer cohorts who have been slamming the same stocks for years are cashing paychecks right now over the .30 fall their article caused. Now they will sit silently for that next raid with who knows what nonsense they can come up with. We have seen it all from every generic will manufacture Vascepa to nobody will want this fish oil. Next they will come up with some article about a possible comet Amrn HQ.
    May 10, 2013. 10:23 AM | 5 Likes Like |Link to Comment
  • Italian OTC Fish Oil Study Has No Bearing On Vascepa Outcomes [View instapost]
    Adam Feuerstein

    Your connections to Stephen D. Simpson and Larry Husten are certainly interesting that put out that articles today regarding AMRN. What are the odds that 2 people put out articles today in an attempt to discredit Amrn that have been bashing the same stocks as you have for years. In fact there is a history of re-tweeting and cross promotion regarding the articles the articles written by them and you not only about AMRN but numerous other stocks. I was wondering how long this attack will continue on AMRN. Scripts have been reported at 11768 for April which is the 3rd full month post launch. Can you tell us exactly what number of scripts you view as success. I have seen you put out articles on other companies with much smaller scripts sales and call it a blowout launch. Some things just do not add up.

    One more question. You claimed in an article that everyone will compete with Vascepa as generics will all come on line and manufacture it. You claim Vascepa is useless fish oil yet on the other hand claim everyone will want to get into the business. Dont make sense does it.
    May 9, 2013. 08:23 PM | 6 Likes Like |Link to Comment
  • Can Amarin Make Me A Believer This Thursday? [View article]
    No problem. Not a big deal. Bond Wells did ask my permission to post it first which I gave him. Anyways not a biggie either way.
    May 6, 2013. 05:01 PM | Likes Like |Link to Comment